Evidence map›Paper›PMID 41711674›Full record

ArticleAnalytical chemistry2026

Suspect Screening and Prioritization as an Analytical Strategy for the Identification of Persistent, Mobile, and Toxic (PMT) Substances in Surface Water.

Lesly Ayala Cabana, Alejandra Arcas, Isabel López-Heras, Ana de Santiago-Martín, Raffaella Meffe

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lesly Ayala CabanaGeography and Environment Department, Faculty of Sciences, University of Alcalá, Geology, External Campus, Ctra. A-II km 33.6, Alcalá de Henares 28871, Madrid, Spain.ORCID 0009-0002-4610-0069
Alejandra ArcasIMDEA Water, Avda Punto Com, 2, Alcalá de Henares 28805, Madrid, Spain.
Isabel López-HerasIMDEA Water, Avda Punto Com, 2, Alcalá de Henares 28805, Madrid, Spain.
Ana de Santiago-MartínIMDEA Water, Avda Punto Com, 2, Alcalá de Henares 28805, Madrid, Spain.
Raffaella MeffeIMDEA Water, Avda Punto Com, 2, Alcalá de Henares 28805, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent, mobile, and toxic (PMT) substances have gained increasing scientific and regulatory attention due to their capacity to bypass natural and artificial barriers and spread throughout the water cycle. However, knowledge of their environmental occurrence remains limited due to analytical challenges, particularly in detecting highly polar substances that are often overlooked in monitoring studies. This study aims to identify PMT substances that are worth monitoring in surface waters strongly influenced by wastewater treatment plant effluents. A suspect screening analysis (SSA) approach based on the use of LC-HRMS was integrated with a tiered prioritization strategy. Our workflow integrates multimodal SPE and LC approaches to improve PMT detection coverage across polarity gradients. A total of 305 substances were tentatively identified, and 103 of them were prioritized as PMT substances, encompassing industrial chemicals, personal care products, pharmaceuticals, illicit drugs, pesticides, and transformation products. Notably, only 13% of PMT substances are currently included in the European Water Framework Directive legislation or the REACH list of substances of very high concern. Among them, 35 high-priority PMT substances were confirmed with analytical standards through mass spectrometry (MS/MS) in tandem with HRMS, providing reliable fragmentation data. Some of these substances such as the pharmaceutical celecoxib, the ultrashort-chain per- and polyfluoroalkyl substance (PFAS) bis(trifluoromethylsulfonyl)imide, or the industrial chemical 1,3-di-

Identifiers

PMID41711674
PMCPMC12961641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.